COVID-19 Resource Center

Innovation is key to emerging from the COVID-19 pandemic and protecting that innovation with IP is essential. Here, we present our COVID-19-related information.

As the world grapples with the COVID-19 pandemic, our attorneys are helping clients navigate the complex intellectual property issues involved in developing testing, treatments, and vaccines, as well as related products and services to combat the disease. Additionally, our thought leaders are publishing articles, leading panel discussions, and serving as sources to the media in order to contribute to the global conversation about solutions to the crisis. Of course, innovation is key to emerging from the pandemic, and protecting that innovation is essential. Here, for your easy reference, we present our content related to COVID-19 and intellectual property considerations. Please do not hesitate to contact us for further information and/or to discuss your specific IP questions and concerns.

Related News & Insights

Articles

August 17, 2021

Waiving Covid-19 Vaccine Patents Won’t Solve the Global Need

Bloomberg Law

In the News

December 21, 2020

How 7 IP Firms Weathered The COVID-19 Pandemic

Law360

In the News

July 24, 2020

Six IP Firms Reveal Post-COVID Management Plans

Managing Intellectual Property